Literature DB >> 2089536

Structural alterations of pancreatic microvasculature in cerulein-induced pancreatitis in the rat.

T M Gress1, R Arnold, G Adler.   

Abstract

Pancreatic microvasculature in cerulein-induced pancreatitis was studied at the electron and light microscopic level. Using a modified model of in situ india ink perfusion, focally a marked reduction of the number of india-ink-filled microvessels was found. The numerical density (NA) of filled microvessels was reduced by 66.7% in pancreatitis. The morphological correlate for this extreme numeric reduction might be a collapse of the lumen of pancreatic microvessels. In the presence of cerulein pancreatitis 42% of pancreatic capillaries had a collapsed lumen as shown by electron microscopy. The endothelium of capillaries in acute pancreatitis demonstrated surface blebbing, the formation of cytoplasmatic vacuoles, edema, and swollen mitochondria. Some capillaries had irregularities at the interendothelial junction, and the majority of examined vessels were surrounded by marked perivascular edema. No strict correspondence between histological signs of pancreatitis and light microscopic and/or ultrastructural microvascular alterations could be demonstrated. Our study emphasizes that alterations of microvasculature are present early in experimental edematous pancreatitis. Therefore, alterations of pancreatic microcirculation seem to be of great importance in the pathogenesis of pancreatic inflammation, and should be the subject of further studies.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2089536     DOI: 10.1007/BF00000046

Source DB:  PubMed          Journal:  Res Exp Med (Berl)        ISSN: 0300-9130


  9 in total

1.  Effects of the bradykinin antagonist, icatibant (Hoe 140), on pancreas and liver functions during and after caerulein-induced pancreatitis in rats.

Authors:  T Griesbacher; C Kolbitsch; B Tiran; F Lembeck
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-11       Impact factor: 3.000

Review 2.  Influencing factors of pancreatic microcirculatory impairment in acute panceatitis.

Authors:  Zong-Guang Zhou; You-Dai Chen
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

3.  Vasoactive mediators and the progression from oedematous to necrotising experimental acute pancreatitis.

Authors:  H Weidenbach; M M Lerch; T M Gress; D Pfaff; S Turi; G Adler
Journal:  Gut       Date:  1995-09       Impact factor: 23.059

4.  Impact of microcirculatory flow pattern changes on the development of acute edematous and necrotizing pancreatitis in rabbit pancreas.

Authors:  E Klar; W Schratt; T Foitzik; H Buhr; C Herfarth; K Messmer
Journal:  Dig Dis Sci       Date:  1994-12       Impact factor: 3.199

5.  Review of experimental animal models of acute pancreatitis.

Authors:  Kim Hue Su; Christine Cuthbertson; Christopher Christophi
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

6.  Pathological events in experimental acute pancreatitis prevented by the bradykinin antagonist, Hoe 140.

Authors:  T Griesbacher; B Tiran; F Lembeck
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739

7.  Qualitative and quantitative contrast-enhanced ultrasonographic assessment of cerulein-induced acute pancreatitis in dogs.

Authors:  S Y Lim; K Nakamura; K Morishita; N Sasaki; M Murakami; T Osuga; H Ohta; M Yamasaki; M Takiguchi
Journal:  J Vet Intern Med       Date:  2014-02-24       Impact factor: 3.333

8.  Pretreatment with Warfarin Attenuates the Development of Ischemia/Reperfusion-Induced Acute Pancreatitis in Rats.

Authors:  Dawid Maduzia; Piotr Ceranowicz; Jakub Cieszkowski; Krystyna Gałązka; Beata Kuśnierz-Cabala; Zygmunt Warzecha
Journal:  Molecules       Date:  2020-05-27       Impact factor: 4.411

9.  Therapeutic Effect of Low Doses of Acenocoumarol in the Course of Ischemia/Reperfusion-Induced Acute Pancreatitis in Rats.

Authors:  Zygmunt Warzecha; Paweł Sendur; Piotr Ceranowicz; Jakub Cieszkowski; Marcin Dembiński; Ryszard Sendur; Joanna Bonior; Jolanta Jaworek; Tadeusz Ambroży; Rafał Olszanecki; Beata Kuśnierz-Cabala; Kaczmarzyk Tomasz; Romana Tomaszewska; Artur Dembiński
Journal:  Int J Mol Sci       Date:  2017-04-21       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.